Viewing Study NCT01261728


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2026-03-02 @ 6:24 PM
Study NCT ID: NCT01261728
Status: COMPLETED
Last Update Posted: 2025-08-08
First Post: 2010-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 10-208
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View